Abstract 3174: Nuvisertib (TP-3654) and Dordaviprone (ONC201) synergize to reduce renal cell carcinoma cell viability
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institutions: Brown University, Trinity Health Grand Rapids
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148730797
Cites:
Cited by:
Related to: